D. Veljovich

发表

Clear cell adenocarcinoma of the vagina in a patient with vaginal endometriosis.

C. Drescher, P. Paley, E. Pizer, 2006, Gynecologic oncology.

Combined weekly topotecan and biweekly bevacizumab in women with platinum‐resistant ovarian, peritoneal, or fallopian tube cancer

B. Goff, H. Gray, P. Paley, 2011, Cancer.

Atypical glandular cells of undetermined significance: a five-year retrospective histopathologic study.

M. Stoler, L. Rice, W. Andersen, 1998, American journal of obstetrics and gynecology.

Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer.

B. Goff, L. Holmberg, D. Veljovich, 2011, Gynecologic oncology.

A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.

P. Paley, C. Isacson, J. Press, 2016, American journal of obstetrics and gynecology.

Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer

P. Paley, C. Shah, T. Beck, 2017, Journal of gynecologic oncology.

Laparoscopic Reoperative Surgery for Incompletely Staged Gynecologic Malignancies

D. Veljovich, 2009 .

Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

R. Schilsky, C. Calfa, E. Garrett-Mayer, 2020, Targeted Oncology.

Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases.

C. Drescher, P. Paley, C. Shah, 2011, American journal of obstetrics and gynecology.

Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology Consortium.

B. Kurland, B. Goff, L. Holmberg, 2008, Gynecologic oncology.

ATYPICAL GLANDULAR CELLS OF UNDETERMINED SIGNIFICANCE : A FIVE-YEAR RETROSPECTIVE HISTOPATHOLOGIC STUDY

M. Stoler, L. Rice, W. Andersen, 1999 .

Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging.

Charles W Drescher, C. Drescher, P. Paley, 2008, American journal of obstetrics and gynecology.

Outcomes after robotic radical hysterectomy as compared to open radical hysterectomy at a single high-volume institution after the institution of a robotic surgery program

C. Drescher, P. Paley, C. Shah, 2013 .

Phase II prospective study of weekly topotecan and bevacizumab in platinum refractory ovarian cancer or peritoneal cancer (OC)

H. Gray, P. Paley, H. Muntz, 2008 .

Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer.

B. Goff, L. Holmberg, D. Veljovich, 2011, Gynecologic oncology.